{"schema_version":1,"experiment_id":"eoa_inverse_innovation_exp07_retrospective_selector60_20260803","cell_code":"E7C017","selector_replication":2,"assessments":[{"blind_id":"CANDIDATE_A","problem_reality_importance":92,"causal_archetype_fit":94,"distinctiveness_prior_art_resilience":43,"operational_specificity":96,"falsifiability_test_quality":96,"adopter_partner_path":88,"deployability_complexity":61,"authority_safety_reversibility":95,"strict_potential":79,"empirical_partner_potential":92,"scrutiny_priority":84,"biggest_visible_risk":"The core immobilized-methanotroph treatment concept looks highly vulnerable to prior art, leaving limited contrast beyond unusually rigorous operating, regeneration, and accounting controls.","rationale":"The proposal targets consequential residual methane with a causally essential reusable biological facilitator, a sharply bounded slipstream, excellent controls, full mass-balance requirements, explicit fallback routing, and decisive multi-cycle falsifiers. A facility partner could test it safely, although variable-gas inhibition, resource demands, and biological/process complexity may prevent useful turnover."},{"blind_id":"CANDIDATE_B","problem_reality_importance":86,"causal_archetype_fit":91,"distinctiveness_prior_art_resilience":38,"operational_specificity":96,"falsifiability_test_quality":96,"adopter_partner_path":89,"deployability_complexity":68,"authority_safety_reversibility":95,"strict_potential":75,"empirical_partner_potential":91,"scrutiny_priority":80,"biggest_visible_risk":"Regenerable selective phosphate sorption and elution is a strongly standard-looking treatment pattern, so the remaining contrastive claim may collapse under prior-art scrutiny.","rationale":"The dilute-phosphorus separation problem is credible and the proposal supplies a complete capture-elution-regeneration mechanism, closed mass balances, hydraulic guardrails, lawful bypass, and a highly informative bench-to-bypass study. Its strongest lane is partner validation of selectivity, media recovery, and eluate usability, but downstream custody and regenerant burdens could erase the claimed leverage."},{"blind_id":"CANDIDATE_C","problem_reality_importance":77,"causal_archetype_fit":86,"distinctiveness_prior_art_resilience":67,"operational_specificity":92,"falsifiability_test_quality":92,"adopter_partner_path":78,"deployability_complexity":71,"authority_safety_reversibility":94,"strict_potential":78,"empirical_partner_potential":94,"scrutiny_priority":86,"biggest_visible_risk":"The proposal assumes cross-organization coordination is the binding delay, when missing consent, field capacity, laboratory capacity, or inherently bespoke science may actually control response time.","rationale":"The broker is causally tied to a recurring trust and coordination barrier rather than serving as decorative administration. Eligibility rules, retained consent authority, exception routing, matched-case metrics, and tabletop-first testing make the decisive uncertainty safely resolvable by partners. Multi-party adoption is difficult, but the proposal retains a potentially meaningful contrast from contact lists, mass alerts, added staffing, and compulsory coordination."},{"blind_id":"CANDIDATE_D","problem_reality_importance":63,"causal_archetype_fit":84,"distinctiveness_prior_art_resilience":35,"operational_specificity":95,"falsifiability_test_quality":97,"adopter_partner_path":91,"deployability_complexity":85,"authority_safety_reversibility":97,"strict_potential":66,"empirical_partner_potential":86,"scrutiny_priority":69,"biggest_visible_risk":"The apparent setup bottleneck may be minor compared with irreducible incubation and interpretation time, while the fixed automated assay lane resembles established laboratory standardization and automation.","rationale":"This is the safest, easiest, and most decisively testable proposal, with unusually strong matched-aliquot controls and rollback. However, the environmental consequence is indirect, the claimed bottleneck is not evidenced beyond assertion, and the intervention has high prior-art vulnerability. A laboratory partner could resolve throughput and bias questions cheaply, but the likely surviving opportunity appears narrower than in the other proposals."}],"rank_order":["CANDIDATE_C","CANDIDATE_A","CANDIDATE_B","CANDIDATE_D"],"top_choice":"CANDIDATE_C","portfolio_observation":"A, B, and D are exceptionally bounded and testable but rely on familiar-looking biofiltration, regenerable sorption, or laboratory-automation patterns. C carries greater organizational adoption risk, yet offers the best balance of a potentially resilient contrastive mechanism and a decisive, authorized empirical-partner study. A follows closely because its importance and causal fidelity justify scrutiny despite substantial prior-art vulnerability.","confidence":"MODERATE"}